Heparin-induced thrombocytopenia: IgG-Mediated platelet activation, platelet microparticle generation, and altered Procoagulant/Anticoagulant balance in the pathogenesis of thrombosis and venous limb gangrene complicating heparin-induced thrombocytopenia

Transfusion Medicine Reviews

Volumn 10, Issue 4, 1996, Pages 249-258

  Warkentin, T E ^a  

^a HAMILTON HEALTH SCIENCES   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; HEPARIN; IMMUNOGLOBULIN G; PROCOAGULANT; THROMBIN;

CLINICAL FEATURE; DISSEMINATED INTRAVASCULAR CLOTTING; GANGRENE; HUMAN; LABORATORY DIAGNOSIS; LUNG EMBOLISM; PATHOGENESIS; REVIEW; THROMBOCYTE ACTIVATION; THROMBOCYTOPENIA; THROMBOSIS; VEIN THROMBOSIS;

EID: 0029852157     PISSN: 08877963     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0887-7963(96)80001-0     Document Type: Article

References (41)

1. Warkentin TE Levine MN Hirsh J Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin N Engl J Med 332 1995 1330 1335
2. (in press) Warkentin TE Kelton JG A fourteen year study of heparin-induced thrombocytopenia Am J Med 1996
3. Warkentin TE Hayward CPM Smith CA Determinants of donor platelet variability when testing for heparin-induced thrombocytopenia J Lab Clin Med 120 1992 371 379
4. Warkentin TE Hayward CPM Boshkov LK Sera from patients with heparin-induced thrombocytopenia generate platelet-derived microparticles with procoagulant activity: An explanation for the thrombotic complications of heparin-induced thrombocytopenia Blood 84 1994 3691 3699
5. Warkentin TE, Elavathil E, Hayward CPM, et al: The pathogenesis of venous limb gangrene complicating heparin-induced thrombocytopenia. (submitted)
6. Weismann RE Tobin RW Arterial embolism occurring during systemic heparin therapy Arch Surg 76 1958 219 227
7. Roberts B Rosato EF Heparin—a cause of arterial emboli? Surgery 55 1964 803 808
8. Natelson EA Lynch EC Alfrey CP Jr Heparin-induced thrombocytopenia. An unexpected response to treatment of consumption coagulopathy Ann Intern Med 71 1969 1121 1125
9. Rhodes GR Dixon RH Silver D Heparin induced thrombocytopenia with thrombotic and hemorrhagic manifestations Surg Gynecol Obstet 136 1973 409 416
10. Babcock RB Dumper CW Scharfman WB Heparin-induced immune thrombocytopenia N Engl J Med 295 1976 237 241
11. Chong BH Pitney WR Castaldi PA Heparin-induced thrombocytopenia: Association of thrombotic complications with heparin-dependent IgG antibody that induces thromboxane synthesis and platelet aggregation Lancet 2 1982 1246 1249
12. Sheridan D Carter C Kelton JG A diagnostic test for heparin-induced thrombocytopenia Blood 67 1986 27 30
13. Kelton JG Sheridan D Santos A Heparin-induced thrombocytopenia: Laboratory studies Blood 72 1988 925 930
14. (letter) Amiral J Bridey F Dreyfus M Platelet factor 4 complexed to heparin is the target for antibodies generated in heparin-induced thrombocytopenia Thromb Haemost 68 1992 95 96
15. Kelton JG Smith JW Warkentin TE Immunoglobulin G from patients with heparin-induced thrombocytopenia binds to a complex of heparin and platelet factor 4 Blood 83 1994 3232 3239
16. Visentin GP Ford SE Scott JP Antibodies from patients with heparin-induced thrombocytopenia/thrombosis are specific for platelet factor 4 complexed with heparin or bound to endothelial cells J Clin Invest 93 1994 81 88
17. Greinacher A Pötzsch B Amiral J Heparin-associated thrombocytopenia: Isolation of the antibody and characterization of a multimolecular PF4-heparin complex as the major antigen Thromb Haemost 71 1994 247 251
18. Warkentin TE Kelton JG Interaction of heparin with platelets, including heparin-induced thrombocytopenia Bounameaux H Low-Molecular-Weight Heparins in Prophylaxis and Therapy of Thromboembolic Diseases 1994 Marcel Dekker Inc New York, NY 75 127
19. Warkentin TE Kelton JG Heparin and platelets Hematol Oncol Clin North Am 4 1990 243 264
20. Warkentin TE Kelton JG Heparin-induced thrombocytopenia Prog Hemost Thromb 10 1991 1 34
21. Ernest D Fisher MM Heparin-induced thrombocytopenia complicated by bilateral adrenal haemorrhage Intens Care Med 17 1991 238 240
22. (abstr) Warkentin TE Soutar RL Panju A Acute systemic reactions to intravenous bolus heparin therapy: Characterization and relationship to heparin-induced thrombocytopenia Blood 80 suppl 1 1992 160a
23. Warkentin TE Hirte HW Anderson DR Transient global amnesia associated with acute heparin-induced thrombocytopenia Am J Med 97 1994 489 491
24. Warkentin TE Heparin-induced skin lesions Br J Haematol 92 1996 494 497
25. Falanga A Ofosu FA Cortelazzo S Preliminary study to identify cancer patients at high risk of venous thrombosis following major surgery Br J Haematol 85 1993 745 750
26. Ofosu FA Levine M Craven S Prophylactically equivalent doses of enoxaparin and unfractionated heparin inhibit in vivo coagulation to the same extent Br J Haematol 82 1992 400 405
27. Ginsberg JS Demers C Brill-Edwards P Increased thrombin generation and activity in patients with systemic lupus erythematosus and anticardiolipin antibodies: Evidence for a prothrombotic state Blood 81 1993 2958 2963
28. Ginsberg JS Demers C Brill-Edwards P Acquired free protein S deficiency is associated with antiphospholipid antibodies and increased thrombin generation in patients with systemic lupus erythematosus Am J Med 98 1995 379 383
29. Bauer KA Broekmans AW Bertina RM Hemostatic enzyme generation in the blood of patients with hereditary protein C deficiency Blood 71 1988 1418 1426
30. Mannucci PM Tripodi A Bottasso B Markers of procoagulant imbalance in patients with inherited thrombophilic syndromes Thromb Haemost 67 1992 200 202
31. Conard J Bauer KA Gruber A Normalization of markers of coagulation activation with a purified protein C concentrate in adults with homozygous protein C deficiency Blood 82 1993 1159 1164
32. Demers C Ginsberg JS Henderson P Measurements of markers of activated coagulation in antithrombin III deficient subjects Thromb Haemost 67 1992 542 544
33. Pfueller SL David R Different platelet specificities of heparin-dependent platelet aggregating factors in heparin-induced thrombocytopenia Br J Haematol 64 1986 149 159
34. Greinacher A Amiral J Dummel V Laboratory diagnosis of heparin-associated thrombocytopenia and comparison of platelet aggregation test, heparin-induced platelet activation test, and platelet factor 4/heparin enzyme-linked immunosorbent assay Transfusion 34 1994 381 385
35. (editorial) Kelton JG Warkentin TE Diagnosis of heparin-induced thrombocytopenia: Still a journey, not yet a destination Am J Clin Pathol 104 1995 611 613
36. ΓIIA receptor genotype in HIT patients Blood 86 suppl 1 1995 537a
37. Sims PJ Faioni EM Wiedmer T Complement proteins C5b-9 cause release of membrane vesicles from the platelet surface that are enriched in the membrane receptor for coagulation factor Va and express prothrombinase activity J Biol Chem 263 1988 18205 18212
38. Sims PJ Wiedmer T Esmon CT Assembly of the platelet prothrombinase complex is linked to vesiculation of the platelet plasma membrane. Studies in Scott syndrome: An isolated defect in platelet procoagulant activity J Biol Chem 264 1989 17049 17057
39. Bevers EM Comfurious P Zwaal RFA Platelet procoagulant activity: Physiological significance and mechanisms of exposure Blood Rev 5 1991 146 154
40. Chang CP Zhao J Wiedmer T Contribution of platelet microparticle formation and granule secretion to the transmembrane migration of phosphatidylserine J Biol Chem 268 1993 7171 7178
41. Greinacher A Alban S Dummel V Characterization of the structural requirements for a carbohydrate based anticoagulant with a reduced risk of inducing the immunological type of heparin-associated thrombocytopenia Thromb Haemost 74 1995 886 892